We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

88 hedge funds and large institutions have $345M invested in GenMark Diagnostics, Inc in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 39 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 26

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

1% less funds holding

Funds holding: 89 → 88 (-1)

12% less capital invested

Capital invested by funds: $392M → $345M (-$47.2M)

100% less call options, than puts

Call options by funds: $1K | Put options by funds: $272K

Holders
88
Holders Change
-1
Holders Change %
-1.12%
% of All Funds
2.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
39
Reduced
26
Closed
9
Calls
$1K
Puts
$272K
Net Calls
-$271K
Net Calls Change
-$289K

Top Buyers

1
CCM
Cadian Capital Management
New York
+$11.5M
2
NC
Northpointe Capital
Michigan
+$11.3M
3
VAM
Visium Asset Management
New York
+$2.9M
4
DCM
Driehaus Capital Management
Illinois
+$2.31M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.13M

Top Sellers

1
JP Morgan Chase
JP Morgan Chase
New York
-$8.1M
2
FAM
Fred Alger Management
New York
-$3.76M
3
Parnassus Investments
Parnassus Investments
California
-$2.99M
4
CCM
Camber Capital Management
Massachusetts
-$2.72M
5
JGC
J. Goldman & Co
New York
-$2.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$2M +$16.4K +1,770 +0.7%
DCM
27
Driehaus Capital Management
Illinois
$1.97M +$2.31M +249,790 New
TCM
28
Tekla Capital Management
Massachusetts
$1.69M – – –
Parnassus Investments
29
Parnassus Investments
California
$1.5M -$2.99M -323,452 -63%
TCIM
30
TIAA CREF Investment Management
New York
$1.45M +$341K +36,895 +25%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.37M -$373K -40,283 -19%
Millennium Management
32
Millennium Management
New York
$1.24M -$126K -13,651 -8%
BIM
33
BlackRock Investment Management
Delaware
$1.15M -$34.8K -3,759 -3%
Charles Schwab
34
Charles Schwab
California
$1.07M +$294K +31,761 +30%
IGIM
35
I.G. Investment Management
Manitoba, Canada
$1.05M +$7.5K +811 +0.6%
AIM
36
Artemis Investment Management
United Kingdom
$853K – – –
Goldman Sachs
37
Goldman Sachs
New York
$627K +$639K +69,103 +651%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$603K -$2.77K -300 -0.4%
TA
39
Teachers Advisors
New York
$577K +$11.7K +1,269 +2%
WMSA
40
Weiss Multi-Strategy Advisers
New York
$559K +$9.25K +1,000 +1%
Mackenzie Financial
41
Mackenzie Financial
Ontario, Canada
$532K +$95.3K +10,300 +18%
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$489K -$19.4K -2,100 -3%
DCM
43
Donaldson Capital Management
Indiana
$484K – – –
AllianceBernstein
44
AllianceBernstein
Tennessee
$443K – – –
CCM
45
Catapult Capital Management
New York
$433K -$185K -20,000 -27%
TD Asset Management
46
TD Asset Management
Ontario, Canada
$422K +$15.7K +1,700 +3%
Swiss National Bank
47
Swiss National Bank
Switzerland
$414K +$77.7K +8,400 +19%
JGC
48
J. Goldman & Co
New York
$393K -$2.32M -250,800 -83%
QSS
49
Quantitative Systematic Strategies
Florida
$383K -$322K -34,802 -42%
Wells Fargo
50
Wells Fargo
California
$376K -$89.3K -9,652 -17%
1
2
3 4

GNMK Hedge Fund Activity: Q3 2015 in Review

88 of the 3,581 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2015, worth a combined $345M — down 12% from $392M a quarter earlier.

Fund positioning in GNMK was balanced in Q3 2015: 9 funds opened new positions, 9 closed out, 39 added to existing stakes and 26 trimmed.

The largest buyer was Cadian Capital Management, adding an estimated $11.5M. The largest seller was JP Morgan Chase, cutting an estimated $8.1M.

  • 88 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2015, down from 89 in Q2 2015.
  • Funds reported $345M of GenMark Diagnostics, Inc stock for Q3 2015, down 12% quarter-over-quarter.
  • 9 funds opened new GenMark Diagnostics, Inc positions in Q3 2015 and 9 closed out, a net change of 0 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q3 2015 was Cadian Capital Management, an estimated $11.5M added.
  • The largest GenMark Diagnostics, Inc seller in Q3 2015 was JP Morgan Chase, an estimated $8.1M sold.

Based on aggregated 13F filings for Q3 2015.